Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05851755 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Italian Lung Cancer Observational Study

Study acronym: LUCENT
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
LUCENT is an observational study focused on malignant pulmonary and tracheo-bronchial disease. It involves a large proportion of reference Italian thoracic surgery centers. The relevance of the study is related to the epidemiology of lung cancer in the world - also known as "Big Killer" - and the high mortality rates both in males and females. The aim of his prospective study is to collect a large bulk of postoperative patients' outcome data and to produce up-to-date descriptive statistics of patients undergoing surgery for lung cancer. These results will be pivotal to compare the clinical results of all the relevant specialities involved in the care of lung cancer such as medical oncologists and radiation oncologists.
Trial Details
NCT Number NCT05851755
Lead Sponsor The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Collaborators: S. Andrea Hospital, Azienda Policlinico Umberto I, Azienda Ospedaliero, Universitaria Pisana, Università degli Studi dell'Aquila, University of Milan, Azienda Ospedaliera di Perugia, Monaldi Hospital, Azienda Ospedaliera di Bolzano, AUSL Romagna Rimini, European Institute of Oncology, Università degli Studi di Ferrara, Azienda Socio Sanitaria Territoriale di Mantova
Conditions
(from sponsor)		 Lung Cancer
Related terms Lung Neoplasms
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov